Healthcare
Active
Memo Therapeutics
Human antibody repertoire platform
Switzerland
multimmune
Diagnostic platforms and focused therapies for cancer patients
Germany
M.O.R.E Medical Solutions
Orthopaedic and trauma surgery solutions
Germany
Presidio Pharmaceuticals
Hepatitis C drug
USA
Exited
ACT Biotech
Targeted, orally available cancer drugs
USA
Exit 2014
AnalytiCon discovery
Natural product small molecules and analogues libraries
Germany
Exit 2013
ArraVasc
Peripheral balloon catheters
Ireland
Exit 2018
astex Pharmaceuticals
Drugs against cancer
USA
Exit 2013
Atto-Tec
Fluorescent dyes
Germany
Exit 2009
axellis
Radiation oncology solutions
United Kingdom
Exit 2022
Biobase
Molecular biology databases and tools
Germany
Exit 2012
Biomax Informatics
Bioinformatics software solutions
Germany
Exit 2020
cerbomed
Non-invasive vagus-nerve stimulation device against epilesy
Germany
Exit 2018
chiracon
Chiral intermediates
Germany
Exit 2008
corassist cardiovascular
Medical devices for treatment of heart failure
Israel
Exit 2015
Curadis
Drugs against hormone-dependent diseases such as breast cancer
Germany
Exit 2020
DeveloGen
Metabolic disorders
Germany
Exit 2009
EffRx Pharmaceuticals
Commercial stage osteoporosis drug
Switzerland
Exit 2022
Envoy Medical
Totally implantable hearing aid
USA
Exit 2007
getemed
Vital signs monitors
Germany
Exit 2007
Hybrigenics Pharma
Drugs against cancer
and screening services
France
Exit 2009 (IPO)
IDM Pharma
Drugs against cancer
USA
Exit 2007 (“cold” IPO)
Isarna Therapeutics
Selective TGF-β oligonucleotide inhibitors
Germany
Exit 2021
Lophius Biosciences
T cell-based research tools and diagnostics
Germany
Exit 2020
mtm Laboratories
Cancer diagnostics
Germany
Exit 2018
myoscience
Pain treatment devices
USA
Exit 2019
NeuroProof
Drug discovery and development services
Germany
Exit 2022
Neurotech Pharmaceuticals
Ophthalmic diseases
USA
Exit 2016
Noxxon Pharma
Drugs against inflammatory and hermatological diseases
Germany
Exit 2007
Paratek Pharmaceuticals
Drugs against infectious diseases
USA
Exit 2014 (IPO)
Philogen
Drugs against angiogenesis-related disorders
Italy
Exit 2013
physioTEC
Orthopaedics for children
Germany
Exit 2017
Pieris Pharmaceuticals
Therapeutic proteins
USA
Exit 2014 (IPO)
sepiatec
Chromatographic devices (HPLC)
Germany
Exit 2012